Option chain shows key data for Genetic Technologies's stock options at various strike prices and expiration dates. Traders use this information to analyze potential trades and assess market sentiment for Genetic Technologies.

Genetic Technologies (OTC:GNTLF) Stock, Option Chain

Genetic Technologies Ltd is an Australia-based molecular diagnostics company that offers predictive testing and assessment tools to help physicians proactively manage women's health. The company has developed BREVAGenplus which is a clinically validated risk assessment test for non-hereditary breast cancer. It also provides genetic testing services including medical testing, animal testing, forensic testing, and plant testing. The company markets BREVAGenplus to healthcare professionals in breast healthcare and imaging centers, as well as to obstetricians/ gynecologists (OBGYNs) and breast cancer risk assessment specialists. The majority of the company's revenue is generated from Australia and the United States. The group has two operating segments: EasyDNA and GeneType/Corporate.

GENETIC TECHS LTD by Genetic Technologies Ltd.

Comments

Genetic Technologies

Genetic Technologies (GNTLF) Options

No option chain data available. Please try again later

Popular Channels

Tools & Features

Partners & Contributors

About Benzinga